Hong Kong-listed fitness tech firm Keep slashed its H1 2025 loss to RMB 36 million, down 78% YoY, and posted RMB 10 million in adjusted profit. It credited improved margins and AI-driven efficiency ...

Customers will get their first look at the collaboration in BMW’s Neue Klasse, starting as early as next year.

Inmo beat Xiaomi to the punch by launching its Air3 glasses in November 2024. But unlike many of its peers, Inmo isn’t ...

Chinese enterprise Horen has raised RMB 130 million in a Series F funding round led by Timesbole to expand full-chain packaging solutions in China and speed up global rollout. The firm aims to scale ...

Zhejiang led GDP growth among China’s six largest provinces in H1 2025 at 5.8%, lifted by strong industrial and export performance. Jiangsu and Henan followed at 5.7%, while Guangdong trailed at 4.2%, ...

Unitree Robotics has begun IPO counseling with China’s securities regulator, with CICC as lead sponsor. The company may file as soon as October and is expected to target the STAR Market. Unitree ...

UBTech Robotics has secured a RMB 90.5 million order from Miyi Automotive Technology for its Walker S robots, the largest contract signed with a single supplier in China for humanoid robotics to date.

Goertek Microelectronics has refiled its listing application with the Hong Kong Stock Exchange. Joint sponsors include CICC, CSCI, CMB International, and UBS. The chipmaker first sought a Hong Kong ...

Neuralink said it completed brain implant surgeries for participants codenamed P8 and P9, the first time it performed two procedures in a single day. Both are reportedly recovering well, the company ...

Netflix is testing generative video tools from Runway AI in content production, a source said. Disney has also trialed the solution but said it has no plans to adopt it. The update adds to growing ...

JD.com has denied a media report that it acquired 70% of Hong Kong grocer Kai Bo Food Supermarket for HKD 4 billion. The report claimed the deal included store and property assets, with founder Lam ...

Wohua Pharmaceuticals has reported a net profit of RMB 44.68 million in H1 2025, up 303.16% YoY, on revenue of RMB 425 million. Basic EPS was RMB 0.08, and the company proposed a cash dividend of RMB ...